TickerFacts.

Pulse Biosciences, Inc. (PLSE): Cost of Revenue

Annual figures by period end, from SEC filings.

$539.0K
Year ended 2025-12-31
$1.18M
Trailing 12 months to 2026-06-30
-64.4%
3-year compound annual growth
$11.94M2020-12-31: $02021-12-31: $1.97M2022-12-31: $11.94M2023-12-31: $02024-12-31: $02025-12-31: $539.0K$539.0K
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$539.0Kn/a2026-02-19, From 2025-01-01
2024-12-31$0n/a2026-02-19, From 2024-01-01
2023-12-31$0-100.0%2024-03-28, From 2023-01-01
2022-12-31$11.94M+506.9%2024-03-28, From 2022-01-01
2021-12-31$1.97Mn/a2023-03-31, From 2021-01-01
2020-12-31$0n/a2023-03-31, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Pulse Biosciences, Inc. (PLSE)2025-12-31$539.0Kn/a
QTREX Quantum Ltd. (QTEX)2025-12-31$287.0Kn/a
Co-Diagnostics, Inc. (CODX)2025-12-31$222.4K-77.7%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$646.0K+139.3%
Flyte Aviation, Inc. (VJET)2025-12-31$63.0K+50.0%
Sintx Technologies, Inc. (SINT)2025-12-31$557.0K-31.3%
RenovoRx, Inc. (RNXT)2025-12-31$327.0Kn/a
PetVivo Holdings, Inc. (PETV)2026-03-31$386.9K+181.0%
SeaStar Medical Holding Corp (ICU)2025-12-31$53.0Kn/a

Compare PLSE, QTEX, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗